Review is major blow for the GMC
Patients who self-manage their anticoagulation treatment ach- ieve a similar level of control as those who are managed by a doctor and suffer fewer adverse events, researchers suggest.
The percentage of patients who achieved target INRs was roughly the same in the two groups of patients, at 59 per cent in those who self-managed and 56 per cent in the controls.
And just 2.2 per cent of self-managing patients had a major complication relating to treatment, compared with 7.3 per cent of the patients who were managed conventionally.
Spanish researchers studied 737 patients divided into two groups self-management using a portable coagulometer and self-adjusting treatment dose, and conventional management at a clinic.
The study, published in the Annals of Internal Medicine (January), also found fewer minor haemorrhages and deaths in the self-managing group. But GPs said robust UK evidence was needed.